← Back to Search

Blood draw at six months for Breast Cancer

N/A
Waitlist Available
Led By Pavani Chalasani
Research Sponsored by University of Arizona
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, three months, and six months
Awards & highlights

Study Summary

This trial will test for biomarkers in patients with breast cancer who are scheduled to start adjuvant hormonal therapy.

Eligible Conditions
  • Breast Cancer
  • Musculoskeletal Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, six months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, six months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Oxylipin Levels
Secondary outcome measures
Pain Levels
Tendon Stiffness

Trial Design

1Treatment groups
Experimental Treatment
Group I: ParticipantsExperimental Treatment5 Interventions
Patients with breast cancer who have completed all their primary treatments (surgery±radiation therapy) and are scheduled to start their adjuvant hormonal therapy.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Initial blood draw
2018
N/A
~30
Blood draw at six months
2018
N/A
~30
SWE ultrasound at six months
2018
N/A
~30
Initial SWE ultrasound
2018
N/A
~30
Blood draw at three months
2018
N/A
~30

Find a Location

Who is running the clinical trial?

University of ArizonaLead Sponsor
514 Previous Clinical Trials
148,243 Total Patients Enrolled
22 Trials studying Breast Cancer
2,536 Patients Enrolled for Breast Cancer
Pavani ChalasaniPrincipal InvestigatorUniversity of Arizona
2 Previous Clinical Trials
436 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there still availability for new participants in this research project?

"This medical investigation is not currently enrolling patients. It was initially posted to clinicaltrials.gov on February 28th 2018 and has been updated as recently as April 13th 2022, however there are a plethora of other trials actively recruiting at this time - 2792 in total."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Evaluation of Blood/Imaging Based Biomarkers, Aromatase Inhibitor Induced Musculoskeletal Syndrome
2018. "Evaluation of Blood/Imaging Based Biomarkers, Aromatase Inhibitor Induced Musculoskeletal Syndrome". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03665077.
~4 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top